Terms: = Liver cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
111 results:
1. Undifferentiated Embryonal Sarcoma of the liver with Epithelioid Features: A Case Report of an Exceptional Histological Heterogeneity among Rare Diseases.
Kersik A; Bracchetti G; Bonomi A; Bovo G; Serena Cuttin M; Germini A; Gjoni E; Granieri S; Cotsoglou C
Ann Ital Chir; 2024; 95(2):119-125. PubMed ID: 38684493
[TBL] [Abstract] [Full Text] [Related]
2. MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.
Zhang Y; Lin W; Yang Y; Zhu S; Chen Y; Wang H; Teng L
Cancer Lett; 2024 Jun; 591():216878. PubMed ID: 38609001
[TBL] [Abstract] [Full Text] [Related]
3. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis.
Deng Z; Zhang W; Peng J; Gao L; Zhang C; Lei K; Gong J; Xiong B
Cardiovasc Intervent Radiol; 2024 May; 47(5):592-603. PubMed ID: 38605220
[TBL] [Abstract] [Full Text] [Related]
4. Treating rare tumors with liver transplantation.
Melehy A; Agopian V
Curr Opin Organ Transplant; 2024 Feb; 29(1):30-36. PubMed ID: 37851086
[TBL] [Abstract] [Full Text] [Related]
5. MRI-Based Radiomics and Deep Learning in Biological Characteristics and prognosis of Hepatocellular Carcinoma: Opportunities and Challenges.
Xia T; Zhao B; Li B; Lei Y; Song Y; Wang Y; Tang T; Ju S
J Magn Reson Imaging; 2024 Mar; 59(3):767-783. PubMed ID: 37647155
[TBL] [Abstract] [Full Text] [Related]
6. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract] [Full Text] [Related]
7. Small bowel neuroendocrine tumours - casting the net wide.
Chetcuti Zammit S; Sidhu R
Curr Opin Gastroenterol; 2023 May; 39(3):200-210. PubMed ID: 37144538
[TBL] [Abstract] [Full Text] [Related]
8. Advances in the genetics of nonalcoholic fatty liver disease.
Ajmera V; Loomba R
Curr Opin Gastroenterol; 2023 May; 39(3):150-155. PubMed ID: 37144531
[TBL] [Abstract] [Full Text] [Related]
9. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract] [Full Text] [Related]
10. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
11. Nutritional support in liver disease - an updated systematic review.
Koretz RL
Curr Opin Gastroenterol; 2023 Mar; 39(2):115-124. PubMed ID: 36821460
[TBL] [Abstract] [Full Text] [Related]
12. Clinical risk factors for patients with ruptured hepatoblastoma in children: a retrospective study from a single center in China.
Chang S; Yang S; Yang W; Qin H; Cheng H; Chang X; Zhu Z; Yin J; Ren Q; Yu S; Wang H
Pediatr Surg Int; 2023 Jan; 39(1):76. PubMed ID: 36622431
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma.
Buyukkor M; Tay F; Karacin C; Duran AO
J Coll Physicians Surg Pak; 2023 Jan; 33(1):32-36. PubMed ID: 36597232
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive Analysis of Prognostic Factors in Advanced Gastric cancer Patients Treated with Chemotherapy.
Cavdar E; Iriagac Y; Avci O; Seber ES
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1420-1424. PubMed ID: 36377008
[TBL] [Abstract] [Full Text] [Related]
15. liver transplantation and portal vein tumour thrombus: futile enterprise?
Bhangui P
Curr Opin Organ Transplant; 2022 Aug; 27(4):312-319. PubMed ID: 36354257
[TBL] [Abstract] [Full Text] [Related]
16. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?
Wang Y; Strazzabosco M; Madoff DC
Curr Oncol Rep; 2022 Dec; 24(12):1741-1750. PubMed ID: 36255606
[TBL] [Abstract] [Full Text] [Related]
17. Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis.
Reichstein D; Brock A; Lietman C; McKean M
Curr Opin Ophthalmol; 2022 Nov; 33(6):585-590. PubMed ID: 36094043
[TBL] [Abstract] [Full Text] [Related]
18. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract] [Full Text] [Related]
20. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
[Next]